Drug-loaded nanoparticles induce immunogenic cell death and efficiently target cells from glioblastoma patients
Our findings suggest that DACHPt-loaded NPs represent a promising therapeutic strategy capable of targeting both tumor cells and tumor-promoting immune cells while inducing ICD.
Authors
- Beatrice Musca
- Giovanna Lollo (ORCID: https://orcid.org/0000-0001-7030-3056)
- Giulia Guerriero (ORCID: https://orcid.org/0000-0002-5018-072X)
- Ada Tushe (ORCID: https://orcid.org/0009-0002-0687-7834)
- Sara Zumerle (ORCID: https://orcid.org/0000-0001-6980-0629)
- Susanna Mandruzzato (ORCID: https://orcid.org/0000-0002-0707-995X)
- Mathieu Repellin (ORCID: https://orcid.org/0000-0003-0613-3667)
- Camilla Bonaudo (ORCID: https://orcid.org/0000-0002-0888-7377)
- Francesco Volpin (ORCID: https://orcid.org/0000-0002-7337-9192)
- Edmund R. Marinelli
- Alessandro Della Puppa (ORCID: https://orcid.org/0000-0001-8058-092X)
- Annavera Ventura (ORCID: https://orcid.org/0000-0001-5433-7512)
- Olga Slukinova
- Giulia Zampardi
Institutions
- Université Claude Bernard Lyon 1 (FR)
- Centre National de la Recherche Scientifique (FR)
- University of Padua (IT)
- Lyon College (US)
- Institut Universitaire de France (FR)
- Laboratoire d'Automatique, de Génie des Procédés et de Génie Pharmaceutique (FR)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- University of Florence (IT)
Publication Details
- Journal
- Nanomedicine
- Published
- 2025-05-06
- DOI
- https://doi.org/10.1080/17435889.2025.2497747
- Citations
- 1
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.67